Latest Publications

Share:

Biden Administration to Increase Tariffs on Chinese Imports in Strategic Sectors

The Biden Administration is increasing Section 301 tariffs on a wide range of Chinese imports for “strategic sectors.” Our International Trade & Regulatory Group examines the plan....more

National Security Act Ushers In Sweeping Changes to Sanctions Regulations

On April 24, 2024, President Biden signed H.R. 815, otherwise known as the National Security Act of 2024. The bill provides emergency appropriations for Ukraine, Israel, Taiwan, humanitarian purposes in Gaza, and various...more

Treasury to Sharpen CFIUS Procedures and Enforcement

Proposed changes to how the Committee on Foreign Investment in the United States (CFIUS) can request information and impose civil penalties signal that CFIUS will increasingly focus on compliance and enforcement. Our...more

Regulatory Recap – Latest Export Control Updates on Advanced Computing and Semiconductor Manufacturing Equipment, End-User...

The United States continues to publish additional export control rules on the semiconductor, advanced computing, and supercomputer industries. Our International Trade & Regulatory Group analyzes the latest export controls...more

White House Executive Order to Regulate Transactions Involving Sensitive Personal Data of Americans

The White House announced that President Biden will sign an executive order designed to protect sensitive data of U.S. persons from exploitation by identified countries of concern.  This executive order is expected to be...more

Commerce Imposes Additional Novel and Complex Export Controls on Chips and Semiconductor Equipment

The United States continues to raise the guardrails on critical technologies necessary to support the semiconductor, advanced computing, and supercomputer industries. Our International Trade & Regulatory Group analyzes the...more

New U.S. Sanctions, Export Controls, and Tariffs Against Russia Mark the One-Year Anniversary of the Russian Invasion of Ukraine

One year later, Russia’s war against Ukraine shows no signs of abating. Our International Trade & Regulatory Group breaks down the latest U.S. sanctions further restraining Russia’s ability to do business with the rest of the...more

Commerce Imposes New Sweeping Export Controls on Chinese Semiconductor, Advanced Computing, and Supercomputer Industries

The U.S. effort to further curtail China’s access to critical technologies necessary to support its semiconductor, advanced computing, and supercomputer industries is roiling supply chains and threatening companies’ revenues....more

UK Government Publishes First Annual Report on New UK National Security & Investment Regime

The UK’s version of the United States’ Committee for Foreign Investment in the United States went into effect January 2022. Our International Trade & Regulatory Group and London competition team summarise key facts,...more

Russian Bond Default and CDS Credit Event: How Did We Get Here and Where Are We Going?

Our Financial Services & Products Group provides background on how Russia defaulted on its eurobonds and discusses the implications for Russian bond and credit default swap positions....more

Structured Finance Spectrum – July 2022

Welcome to the latest edition of the Spectrum, covering hot-topic issues in the structured finance markets in the U.S. and UK. Guest edited by our London team, this edition focuses on the opportunities that come from stressed...more

U.S. and Allies Continue to Expand Sanctions Against Russia and Belarus

As Russia’s war against Ukraine continues and the United States and its allies announce further sanctions, U.S. companies face more difficulties with compliance and the loss of valuable assets. Our International Trade &...more

Additional Sanctions, Export Control Restrictions Imposed on Russia, Belarus by U.S. and Allies

Our International Trade & Regulatory Group continues its investigation of the ever-growing sanctions regimes imposed on Russia since its invasion of Ukraine. ...more

The United States and Its Allies Impose Unprecedented Sweeping “Second Tranche” of Economic Sanctions and Export Controls in...

The United States and its allies respond to Russia’s invasion of Ukraine with even tougher sanctions against Russia, its leaders, and its leading businesses. Our International Trade & Regulatory Group breaks down the...more

U.S. and Allies Impose “First Tranche” of New Economic Sanctions in Response to Russian Action in Ukraine

Our International Trade & Regulatory Group addresses the new U.S. sanctions against Russia announced this week in response to its actions against Ukraine and summarizes the similar packages announced by key U.S. allies....more

FDA Suspends Non-Mission-Critical Domestic and Foreign Inspections – Medical Products Supply Chain Week in Review

Just before the New Year holiday, the FDA announced it that was suspending non-mission-critical domestic and foreign inspection activities. The FDA amended the EUA of the Moderna COVID-19 vaccine booster. The Center for Drug...more

FDA Authorizes Booster Dose for Adolescents – Medical Products Supply Chain Week in Review

Over the holidays, the CDC updated its recommendations for post-exposure quarantining and masking. The FDA authorized the Pfizer vaccine booster dose for adolescents 12–15 years of age and for immunocompromised children 5–11...more

FTC to Probe Supply Chain Issues of Major Companies – Medical Products Supply Chain Week in Review

In the past two weeks, the Federal Trade Commission (FTC) has ordered major U.S. companies to provide information on their supply chain issues and solutions. The FDA issued an emergency use authorization (EUA) for a...more

Congressional Compromise Means Importers Should Start Preparing for New Xinjiang Forced Labor Legislation

Congress announced a compromise on the Uyghur Forced Labor Prevention Act this week, and the House passed the bill last night. Our International Trade & Regulatory Group details the bill’s enforcement strategy requirements...more

Pfizer and BioNTech to Request Approval for Vaccine Use in 12-to-15-Year-Olds – Medical Products Supply Chain Week in Review

In the past week, Pfizer and BioNTech announced they will request full approval from the FDA for the use of their COVID-19 vaccine in adolescents 12–15 years of age. They also plan to seek authorization of the booster dose in...more

Medical Products Supply Chain Week in Review – FDA Authorizes Pfizer and Moderna Booster for All Adults

In the past week, the FDA authorized the Pfizer and Moderna booster shots for all adult age groups, while the CDC Advisory Committee on Immunization Practices (ACIP) also recommended the Moderna vaccine booster for all...more

Medical Products Supply Chain Week in Review – November 2021 #2

In the past week, the President has selected Dr. Robert Califf to be FDA commissioner. Congress passed the Infrastructure Investment and Jobs Act. New vaccination requirements were issued by OSHA and CMS for certain...more

Medical Products Supply Chain Week in Review – November 2021 #1

In the past week, the FDA granted an EUA for the Pfizer-BioNTech vaccine for use in children 5–11 years of age. The agency also participated in the launch of the Bespoke Gene Therapy Consortium. The Administration held a...more

Medical Products Supply Chain Week in Review – October 2021 #2

Last week, the FDA authorized the booster doses for both the Moderna and Johnson & Johnson (J&J) COVID-19 vaccines and mix and match booster doses. The FDA also proposed a new rule for over-the-counter (OTC) hearing aids. The...more

59 Results
 / 
View per page
Page: of 3

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide